These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4237949)

  • 61. [Therapeutic experience with the lipotropic hepatic drug Flacar in the internal medicine practice].
    Kandziora J
    ZFA (Stuttgart); 1976 Oct; 52(30):1561-3. PubMed ID: 997758
    [No Abstract]   [Full Text] [Related]  

  • 62. [Clinical experience with silymarin in the treatment of chronic liver disease(author's transl)].
    Reutter FW; Haase W
    Schweiz Rundsch Med Prax; 1975 Sep; 64(36):1145-51. PubMed ID: 1099576
    [No Abstract]   [Full Text] [Related]  

  • 63. Orotate prevents galactosamine hepatitis.
    Keppler D; Rudigier J; Reutter W; Lesch R; Decker K
    Hoppe Seylers Z Physiol Chem; 1970 Jan; 351(1):102-4. PubMed ID: 5411959
    [No Abstract]   [Full Text] [Related]  

  • 64. Effects of nucleic acid precursors on liver injuries. II. The influences of AICA and AICA orotate on metabolisms in liver injuries and their clinical significances.
    Hashimoto S
    J Vitaminol (Kyoto); 1967 Mar; 13(1):19-25. PubMed ID: 6059490
    [No Abstract]   [Full Text] [Related]  

  • 65. [Effects of a new preparation of purinic and orotic acid base in chronic liver diseases].
    ALLODI A; MURATORI F
    Gazz Med Ital; 1957 May; 116(5):214-23. PubMed ID: 13448337
    [No Abstract]   [Full Text] [Related]  

  • 66. [Pharmacological studies on liver-acting agents 2. Effects of so-called liver drugs on the ethionine-damaged liver].
    Kobayashi T
    Nihon Yakurigaku Zasshi; 1966 Nov; 62(6):361-88. PubMed ID: 5339555
    [No Abstract]   [Full Text] [Related]  

  • 67. [Clinical study on the treatment of liver disease with glucocorticoids].
    Oda T; Suzuki H; Naito C; Yamanada M; Oka H
    Saishin Igaku; 1969 Oct; 24(10):2119-29. PubMed ID: 5349229
    [No Abstract]   [Full Text] [Related]  

  • 68. [Liver protecting effects of a nucleotide precursor on acute and subacute hepatitis induced by ethanol. Concerted cellular enzymologic investigation].
    Wegmann R; Marcy J
    Ann Histochim; 1970; 15(4):245-61. PubMed ID: 5535139
    [No Abstract]   [Full Text] [Related]  

  • 69. [Pharmaco-metabolic activity in chronic hepatopathies: influence of treatment with UDPG].
    Okolicsànyi L; Orlando R; Lirussi F; Naccarato R; Dal Brun G
    Clin Ter; 1980 May; 93(4):431-8. PubMed ID: 6998643
    [No Abstract]   [Full Text] [Related]  

  • 70. [Therapeutic activity of 2,4-dihydroxy-6-pyrimidine carbonate of 4-amino-5-carbamide-imidazole].
    Pasotti C
    Clin Ter; 1975 Nov; 75(3):281-9. PubMed ID: 776509
    [No Abstract]   [Full Text] [Related]  

  • 71. [The anti-steatosic effect of sulfo-adenosylmethionine (SAMe) in various forms of chronic hepatopathy. Multicentric research].
    Mazzanti R; Arcangeli A; Salvadori G; Smorlesi C; Di Perri T; Auteri A; Boggiano CA; Pippi L; Toti M; Boncompagni P; Angioli D; Caremani M; Magnolfi F; Camarri E; Motta R; Forconi A; Candidi Tommasi A; Lomi M; Soldi A
    Minerva Med; 1978 Oct; 69(48):3283-92. PubMed ID: 724140
    [No Abstract]   [Full Text] [Related]  

  • 72. [Use of lipoic acid and its amide in chronic liver diseases].
    Romanov VS
    Sov Med; 1971; 34(12):43-5. PubMed ID: 4948129
    [No Abstract]   [Full Text] [Related]  

  • 73. [Effect of anabolic steroids on protein metabolism under various protein administrations in chronic liver disease patients].
    Blahníková L; Horký J
    Z Ernahrungswiss Suppl; 1972; 13():105-12. PubMed ID: 4510113
    [No Abstract]   [Full Text] [Related]  

  • 74. [Alcoholic hepatopathy].
    Dusi U; Dalla Vestra P; Zanetto B
    Minerva Med; 1970 Jan; 61(7):240-2. PubMed ID: 5413858
    [No Abstract]   [Full Text] [Related]  

  • 75. [Increase of appetite by Nuran in liver diseases].
    Hilt G; Bungeroth KA
    Munch Med Wochenschr; 1971 Jan; 113(3):91-4. PubMed ID: 5276193
    [No Abstract]   [Full Text] [Related]  

  • 76. [Long-term therapy of liver diseases].
    Markoff N
    Wien Med Wochenschr; 1972 Feb; 122(7):95-9. PubMed ID: 4621921
    [No Abstract]   [Full Text] [Related]  

  • 77. [Experiences with potassium orotate in hyperuricemic subjects].
    Spanio L; De Battisti C
    Acta Vitaminol; 1965 Dec; 19(5):215-8. PubMed ID: 5899061
    [No Abstract]   [Full Text] [Related]  

  • 78. [Clinical study of citiolone, cyto-membranous hepatic protector].
    Varay A; Castel A; Bloch J
    Therapeutique; 1970 Dec; 46(10):993-5. PubMed ID: 5511936
    [No Abstract]   [Full Text] [Related]  

  • 79. [Effects of treatment with nucleotides and aspartic acid in chronic liver diseases].
    Iencica R
    Med Interna (Bucur); 1972 Dec; 24(12):1449-53. PubMed ID: 4655566
    [No Abstract]   [Full Text] [Related]  

  • 80. [Sorbitol in therapy of hepato-biliary diseases].
    PICCINELLI O; TIMOSSI G
    Minerva Med; 1958 Jan; 49(3-4):77-82. PubMed ID: 13516734
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.